Skip to content
Search

Latest Stories

COVID-19 death toll in India climbs to 199; 6412 cases

The death toll due to COVID-19 rose to 199 in India and the number of cases stands at 6,412 on Friday (10), according to the health ministry.

While the number of active COVID-19 cases is 5,709, as many as 503 people were cured and discharged and one had migrated, it said.


The ministry said at least 30 new deaths have been reported since Thursday (9) evening.

Twenty-five deaths were reported from Maharashtra, three from Delhi and one each from Gujarat and Jharkhand.

The 6,412 figure includes 71 foreign nationals.

Maharashtra has reported the most coronavirus deaths at 97, followed by Gujarat at 17, Madhya Pradesh 16 and Delhi 12.

Punjab and Tamil Nadu have reported eight fatalities each while Telengana has reported seven deaths.

West Bengal and Karnataka have registered five deaths each. Andhra Pradesh, Jammu and Kashmir and Uttar Pradesh have reported four deaths each while Haryana and Rajasthan have recorded three deaths each.

Two deaths have been reported from Kerala. Bihar, Himachal Pradesh, Odisha and Jharkhand reported one fatality each, according to the health ministry data.

According to the ministry's data updated in the morning, the highest number of confirmed cases in the country are from Maharashtra at 1,364, followed by Tamil Nadu at 834 and Delhi with 720 cases.

The cases have gone up to 463 in Rajasthan, while they have risen to 442 in Telengana   Uttar Pradesh has 410 cases so far, followed by Kerala at 357 cases. Andhra Pradesh has reported 348 coronavirus cases

Novel coronavirus cases have risen to 259 in Madhya Pradesh, 241 in Gujarat,  181 in Karnataka and 169 in Haryana.      Jammu and Kashmir has 158 cases, West Bengal has 116 and Punjab has 101 positive patients so far.

Odisha has reported 44 coronavirus cases. Thirty-nine people were infected with the virus in Bihar while Uttarakhand has 35 patients and Assam 29.

Chandigarh and Himachal Pradesh have 18 cases each while Ladakh has 15 and Jharkhand has 13 positive patients so far.

Eleven cases have been reported from the Andaman and Nicobar Islands while 10 were reported from Chhattisgarh.

Goa has reported seven COVID-19 infections, followed by Puducherry at five cases. Manipur has two while Tripura, Mizoram and Arunachal Pradesh have reported one case each.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less